ScoreWhy is SMS Pharmaceuticals Ltd ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.23% and Operating profit at 10.22% over the last 5 years
2
Stock is technically in a Mildly Bearish range
- A key technical factor - Bollinger Band has been Bearish since 08 Apr 2025
3
37.6% of Promoter Shares are Pledged
- In falling markets, high promoter pledged shares puts additional downward pressure on the stock prices
- The proportion of pledged holdings has increased by 18.2% over the last quarter
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Drugs)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is SMS Pharma. for you?
High Risk, Medium Return
Absolute
Risk Adjusted
Volatility
SMS Pharma.
-1.45%
-0.02
53.33%
SENSEX
0.45%
0.03
14.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
13.23%
EBIT Growth (5y)
10.22%
EBIT to Interest (avg)
4.37
Debt to EBITDA (avg)
2.88
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.80
Tax Ratio
25.94%
Dividend Payout Ratio
4.08%
Pledged Shares
37.60%
Institutional Holding
2.51%
ROCE (avg)
10.67%
ROE (avg)
9.18%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
25
Industry P/E
33
Price to Book Value
2.98
EV to EBIT
19.90
EV to EBITDA
14.82
EV to Capital Employed
2.33
EV to Sales
2.50
PEG Ratio
0.36
Dividend Yield
0.20%
ROCE (Latest)
11.27%
ROE (Latest)
10.53%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend13What is working for the Company
ROCE(HY)
Highest at 11.84%
OPERATING PROFIT TO INTEREST(Q)
Highest at 7.91 times
DEBT-EQUITY RATIO(HY)
Lowest at 0.51 times
PAT(Q)
At Rs 18.24 cr has Grown at 23.0% (vs previous 4Q average
EPS(Q)
Highest at Rs 2.15
-2What is not working for the Company
NET SALES(Q)
At Rs 173.35 cr has Fallen at -9.8% (vs previous 4Q average
Loading Valuation Snapshot...
Here's what is working for SMS Pharma.
Operating Profit to Interest - Quarterly
Highest at 7.91 times
in the last five quartersMOJO Watch
The company's ability to manage interest payments is improving
Operating Profit to Interest
Profit After Tax (PAT) - Quarterly
Highest at Rs 18.24 cr.
in the last five quartersMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Profit After Tax (PAT) - Quarterly
At Rs 18.24 cr has Grown at 23.0% (vs previous 4Q average)
over average PAT of the previous four quarters of Rs 14.84 CrMOJO Watch
Near term PAT trend is positive
PAT (Rs Cr)
Earnings per Share (EPS) - Quarterly
Highest at Rs 2.15
in the last five quartersMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (Rs)
Debt-Equity Ratio - Half Yearly
Lowest at 0.51 times
in the last five half yearly periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for SMS Pharma.
Net Sales - Quarterly
At Rs 173.35 cr has Fallen at -9.8% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 192.12 CrMOJO Watch
Near term sales trend is negative
Net Sales (Rs Cr)
Non Operating Income - Quarterly
Highest at Rs 2.13 cr
in the last five quartersMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating Income
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
